——The 2021 (first) China Smart Medical Innovation and Entrepreneurship Development Forum was successfully held at China Europe International Business School
Focus News Cable TV Online Shanghai Channel Reporter Zhou Liqiang Yesterday (October 23), the 2021 (first) China Smart Medical Innovation and Entrepreneurship Development Forum was successfully held at China Europe International Business School. The forum was jointly sponsored by the China-Europe Alumni Smart Medical Entrepreneurship Association, the China-Europe Smart Medical Research Institute and the Investment and Financing Branch of the China Non-public Medical Institutions Association. Co-organized by China Europe International Business School Executive Education Curriculum Department, Shanghai MaisiShusheng Culture Exhibition Industry Development Co., Ltd., Beijing Orange Health Management Co., Ltd., Roentgen (Shanghai) Medical Technology Co., Ltd., and supported by Qidong Health and Life Science and Technology Park.
(The forum was hosted by Huang Yinzhi, founding partner of Sharing Investment and president of the CeIBS Alumni Smart Medical Entrepreneurship Association)
Academician Li Lanjuan of the Chinese Academy of Engineering (video), Academician of the Chinese Academy of Engineering Wang Weiqi, Academician of the Chinese Academy of Sciences Huang Hefeng, President of China Europe International Business School Professor Wang Hong, Former Dean of China Europe International Business School Professor Zhu Xiaoming, Deputy Governor of Shanghai Pudong New Area Li Guohua, Vice Provost of Ceio, Professor Wang Gao of International Business School Marketing, President of China Europe Smart Medical Entrepreneurship Association Huang Zhizhi, President of China Non-public Medical Institutions Association Investment and Financing Branch Shan Junbao, etc. joined hands with 30 industry leaders to attend the forum, with a total of 30 new drug research and development More than 400 academic experts, industry authorities, industry leaders, medical entrepreneurs and medical investors in the five major medical fields of biotechnology, innovative devices, medical services and medical investment attended the conference, and more than 4,000 people watched the conference online.
The launching ceremony of the forum (from left to right): Li Guohua, Deputy Governor of Pudong New Area, Shanghai, Former Dean of China Europe International Business School, Professor Zhu Xiaoming, Academician Huang Hefeng of Chinese Academy of Sciences, Academician Wang Weiqi of Chinese Academy of Engineering, Dean of China Europe International Business School, Professor of Management, Professor of Management of Hengdian Group, Professor of Management Wang Hong, President of CICC Capital, President of China Non-public Medical Institutions Association Investment and Financing Institution Branch Shan Junbao, Founder of Zejing Biotech Dr. Sheng Zelin, Founder of Suoyuan Pharmaceutical Dr. Luo Wen, President of CEIBS Alumni Smart Medical Entrepreneurship Association and Founding Partner of Shared Investment Huang Vice)
In the face of more than 400 innovators, practitioners and more online participants in China's medical industry gathered at the forum, Huang Hefeng, academician of the Chinese Academy of Sciences and chair professor of Fudan University, shouted loudly, calling on the innovative entrepreneurs in China's medical industry to be brave enough to unveil the list and undertake the mission of the times!
Academicians talk about smart medical care
Li Lanjuan, an academician of the Chinese Academy of Engineering, pointed out that based on the combination of emerging technologies such as mobile Internet, wearable devices, and big data and new business models, China is comprehensively subverting the cognitive structure of medical treatment, and China has gradually entered a new stage of smart medical care, and the smart medical industry will also promote the construction of "Healthy China". In the future, the medical industry will integrate more artificial intelligence, sensing technology and other high-tech technologies to make medical services move towards the true meaning of intelligence. In the new era, the deep integration of big data, artificial intelligence and medical health has extraordinary value and significance.
(Academician Li Lanjuan, Chinese Academy of Engineering)
The innovation and breakthrough of "card neck technology" in the field of medical treatment in China is one of the topics focused on this forum. Wang Weiqi, academician of the Chinese Academy of Engineering and chief professor of Fudan University, interpreted the (2021 edition) industrial base development catalog, especially in medical-related key areas. At present, China must do a good job in the battle of upgrading the industrial base and modernizing the industrial chain, and the purpose of industrial catalog compilation is to provide reference for the government's organizational research and provide guidance for the focus of social capital. The medical industry has become the focus of competition in major countries, and high-end medical equipment has become a national strategy. In today's era of growing demand for a better life, the pharmaceutical industry has a lot to do.
(Academician Wang Weiqi, Chinese Academy of Engineering)
Academician Huang Hefeng pointed out that in the past meeting of academicians of the two academies, the national level proposed that the breakthrough of "card neck technology" should implement a new mechanism of "unveiling the commander- and horse racing", that is, the state is recruiting talents in the list, and she hopes that China's innovative entrepreneurs should have the courage to undertake the mission of the current era: "Ride a horse to unveil the list posted by the state" and lead the military order! "From the previous academicians' interpretation of the country's strategy, we can know what the country needs, what should we innovate in the market, what should we invest in, otherwise what will we do in Central Europe?" Making money is certainly not the last resort! ”
(Academician Huang Hefeng, Chinese Academy of Sciences)
Wang Hong, Dean of China Europe International Business School, Professor of Management and Chair Professor of Management of Hengdian Group, warmly congratulated the opening of the "2021 (First) China Smart Medical Innovation and Entrepreneurship Development Forum", pointing out that "the last mile of smart medical, precision medicine and scientific medical research is directly in creating human happiness". She praised Professor Zhu Xiaoming, former dean of CEIBS and chairman of the Academic Committee of CEIBS, and many academicians for taking responsibility from the perspective of the overall situation, forward-looking vision, national mission and sense of responsibility in academia, and thanked CEIBS alumni for their positive performance in supporting CeIBS and China's economic construction.
(Wang Hong, Dean of China Europe International Business School, Professor of Management, Chair Professor of Management of Hengdian Group)
Professor Zhu Xiaoming shared the 10-year history and academic achievements of CEIBS in the field of smart healthcare, and was full of expectations for the future of smart healthcare. He said that nowadays, evidence-based medicine, clinical medicine, precision medicine, translational medicine, etc. in medicine are in urgent need of digitization, intelligence and intelligence, and the CeIBS smart medical entrepreneurship course is opportune and appropriate. "Doctors are now receiving a lot of quantified data 24 hours a day, 7 days a week, and all of this is still accelerating further, and within 10 years we will live in a world where almost everything that can be measured will be continuously measured." He suggested that the next forum of the association and the next stage of the research institute can be more diverse, such as: 1, radiological imaging: visual intelligence, deep learning, new research on convolutional models; 2, medical service transformation: new achievements in digital solutions; 3, the development of traditional Chinese medicine: the integration of hope and hearing and digitalization and intelligence; 4, industry-university-research medicine: the entrepreneurship and innovation theme forum for students of the 1-6 cessibal smart medical class; 5, the special speech: academician dean, Famous doctor forums (such as oral dentists who are already in the making) and so on.
(Zhu Xiaoming, Former Dean, Professor of Management, Director of CEIBS Smart Medical Entrepreneurship Course, And Chair Professor of Management of Zhongtian Group)
Shan Junbao, president of the Investment and Financing Branch of the China Association of Non-public Medical Institutions and president of CICC Capital, pointed out that no industry in China can combine three major dividends like the pharmaceutical and medical health industry: both the dividends brought by industrial change, the dividends brought by policy reforms and the help of the capital market. "The investment community often says that it is better to miss than to make mistakes, but many people in biomedicine often say that it is better to invest in the wrong than to miss." You may have shot a racer wrong, but you can't miss an era. ”
(Shan Junbao, President of Investment and Financing Branch of China Non-public Medical Association and President of CICC Capital)
Li Guohua, deputy mayor of Pudong New Area, said that Pudong New Area is very willing to work with China and Europe to build the best and most reputable biomedical and digital medical industry foundation in Pudong.
(Pudong New Area Deputy Governor Li Guohua)
Chinese-style medical innovation is exciting
In the second half, the keynote speeches and roundtable forums in the five major fields showcased the breakthrough products and technologies of many of China's leading innovative medical enterprises, as well as the understanding and discussion of the industry by many outstanding entrepreneurs.
In the special session of new drug research and development, Dr. Sheng Zelin, the founder of Zejing Bio, shared the local innovative drug research and development strategy, pointing out that product differentiation is the basis for the survival of local innovative drug companies. As a Chinese enterprise, in the current strategy, Zejing Bio is fully capable of achieving differentiated products through the design and technological innovation of differentiated pipelines, which will have a very strong competitive advantage in China and even in international competition. Dr. Luo Wen, founder of Suoyuan Pharmaceutical, introduced the subversive breakthrough in the business model of Suoyuan Pharmaceutical in the context of the long research and development cycle and huge risks of biomedicine, that is, using core technologies and data-oriented to discover new biomarkers and solve the dilemma of innovative drugs in China.
(New drug research and development special roundtable discussion: Dr. Luo Wen, founder of Suoyuan Biology, Dr. Liu Binlei, founder of Binhui Biology, Dr. Liu Shumin, founder of Kangyuan Jiuyuan, Dr. Sheng Zelin, founder of Zejing Biology, Dr. Li Hangwen, founder of Si Microbiology, and Dr. Zheng Weiyi, founder of Yingnuo Pharmaceutical, attended to discuss the differentiated research and development strategy and internationalization of innovative drugs.) ）
In the biotechnology session, Dr. She Zhending, founder of Shenzhen Landu Biology, analyzed the current situation in the field of biomedical materials, especially in the field of regenerative medicine and high-end products, and was optimistic about the potential of domestic innovative enterprises. Dr. Mingen Xu, founder of Genofei Biologics, introduced the key technologies and application areas of biological 3D printing technology, which is a platform technology that can promote many aspects of the medical field.
(Special roundtable discussion on biotechnology: Dr. She Zhending, founder of Landu Biology, Chen Yiding, founder of Baipusais, Wang Sizhen, founder of Panshengzi, Dr. Xu Mingen, founder of Jienuofei, Xia Jiang, founder of Pilot Gene, and Zhou, founder of Huarui Tongkang, exchanged their initial entrepreneurial intentions and understanding of the trends in their respective segments in the absence of mature commercialization paths.) ）
In the medical device session, Dr. Yuan Yuyu, founder of Maipu Medical, analyzed the strategies of overseas medical device companies to attach importance to the construction of underlying technology and the creation of an entrepreneurial atmosphere, and to achieve multi-product layout and enhance competitiveness with the help of acquisitions. He also shared the experience of Maxple Medicine in innovating implantable medical devices around the biotechnology platform, resulting in more and better innovation through the combination of cross-cutting technology fields. Dr. Yuan Yuyu, founder of Tongxin Medical, shared the historical background of the development of the industry in the international "artificial heart" route dispute, as well as the real process of domestic high-end innovative medical device products "going to sea" under the premise of differentiated competitiveness.
(Medical Device Roundtable Discussion: Dr. Yuyu Yuan, founder of Maipu Medical, Dr. Chen Chen, founder of Tongxin Medical, Dr. Li Weigong, founder of Weigong Technology, Wang Hao, President of Siemens Healthcare Greater China, Dai Ying, Vice President and Chief Innovation Officer of GE Healthcare China, and Yu Qifeng, founder of New Pulse Medical, shared the many challenges of insisting on innovation, as well as the opportunity topics of Chinese enterprises and the Chinese market.) ）
In the medical service session, Dr. Yu Rong, founder of Meinian Health, shared his expectations for the future progress of medical services in digitalization, the global medical service industry is accelerating the pace of digital transformation, and the trend towards the front is becoming more and more obvious, and it can be expected that there will be greater progress in the field of digital medical care, especially in the field of medical services. He believes that the health management industry in the next 10 years combined with digital technology is an opportunity to become a very competitive and diversified profit model of important track. Especially after the epidemic, the realization of digital chronic disease management and digital technology will bring great improvement to the industry.
Feng Xiaoyuan, founder of Roentgen Medical, honorary chairman of the Radiology Branch of the 15th Chinese Medical Association and chairman of the Shanghai Biomedical Engineering Society, pointed out that since the 21st century, medicine has shifted from treatment to prevention, from disease-centered to human-centered, and "medicine has moved from tradition to wisdom". Through the advancement of technology, more devices such as IVD devices can be popularized in the home, so that medical care can be returned to the family, and the accessibility and fairness of medical treatment can be solved. With the help of AI, better tools and methods are used to control people's healthy rhythms, forming a closed loop, and I believe that everyone's health and life expectancy will be extended.
(Special roundtable discussion on medical services: Professor Feng Xiaoyuan, founder of Roentgen Medical, chaired by Professor Duan Tao, the sixth chairman of the Chinese Perinatal Society, Dr. Sun Yan, founder of Happy Dental, Song Tao, founder of Mega Health, Dr. Yu Rong, founder of Meinian Health, and Zhao Songqing, chairman of Orange Health, attended the exchange of expectations and ideas for future medical treatment, as well as how to innovate the medical service model.) ）
At the medical investment session, Shan Junbao, president of the Investment and Financing Branch of the China Non-public Medical Association and president of CICC Capital, introduced the global medical and medical boom in recent years and the feast of the IPO of China's pharmaceutical and medical industry, and also shared the changes in the investment community's views on domestic biomedical investment: for example, the development of innovative drugs, reflecting the three keywords of source innovation, scientific and technological empowerment, and participation in global competition; medical devices embodying import substitution, minimally invasive intervention, and integrating the market keywords. The future development space of China's pharmaceutical and medical health is still very huge, and I hope that everyone will work together to usher in a new era of Investment in China's pharmaceutical and medical health.
Huang Zhi, founding partner of Sharing Investment and president of the CEIBS Alumni Wisdom Medical Entrepreneurship Association, shared the investment logic of four major categories: precision medicine, import substitution, investment opportunities combined with scientific and technological progress in addition to biomedicine, and the huge opportunities brought about by consumption upgrading, especially the in-depth understanding of the new trend of medical and health investment driven by the two-wheel drive of "precision medicine" and "consumption upgrade". In the field of precision medicine, the focus is on the transformation of the health industry from the upstream, middle and downstream changes to a detailed analysis of its impact on the health industry, such as the key upstream raw materials of precision medicine have changed from chemical to biological, from inactive to active, which represents the future direction. Sharing investment is based on precision medicine as the main line, innovation-driven as the core, based on the frontier, facing the future, to find those products and services that have real innovative value, but also pay attention to the huge opportunities brought about by consumption upgrades.
(Medical Investment Roundtable Discussion: Sharing Investment Founding Partner and President of CEIBS Alumni Wisdom Medical Entrepreneurship Association Huang Vice chaired by Chen Penghui, Founding Partner of Boyuan Capital, Hong Tan, Managing Director of Legend Capital, Li Wengang, Managing Director of Yunfeng Fund, Shan Junbao, President of CICC Capital Operation Co., Ltd. and President of The Investment and Financing Institution Branch of China Non-public Medical Institutions Association, and Zhang Leidi, Managing Director of China Life Equity Investment, talked about the impact of capital market reform on the field of biomedical investment. Investment strategy choices for innovative devices. ）
(Group photo of forum speakers)
Expectations for the forum
Academician Li Lanjuan pointed out in her speech that in the face of the threat of the new crown epidemic and the new scientific and technological revolution, industrial change and community governance innovation in the world, it is hoped that in promoting the innovative development of China's smart medical care, the CeIBS Smart Medical Research Institute and the CEIBS Alumni Smart Medical Entrepreneurship Association carry the mission of leading the reform and development of the smart medical industry and provide a broader soil for the majority of smart medical entrepreneurs.
Huang Said, on behalf of the organizers, this forum is the first innovation and entrepreneurship forum after the establishment of the CeIBS Alumni Smart Medical Entrepreneurship Association and the CEIBS Smart Medical Research Institute, and the participants here today feel the new vision and new tentacles of medical treatment, as well as the pulse and future trend of the industry. The forum will continue to be held and make due contributions to the development of the smart medical industry.